West Paces Advisors Inc. Edwards Lifesciences Corp Transaction History

West Paces Advisors Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Dec 18, 2023	BUY	$101.96 - $128.34 $7,341 - $9,240	72 New	72 $8.48 Million
Q4 2021 Dec 19, 2023	SELL	$106.37 - $130.68 $3,191 - $3,920	-30 Reduced 29.41%	72 $9.33 Million
Q2 2020 Dec 19, 2023	BUY	$57.54 - $76.95 $5,869 - $7,848	102 New	102 $7.05 Million
Q3 2018 Dec 20, 2023	BUY	$45.7 - $58.03 $1,553 - $1,973	34 New	34 $5.92 Million
Q2 2018 Dec 21, 2023	BUY	$42.45 - $51.3 $424 - $513	10 Added 41.67%	34 $4.95 Million
Q4 2017 Dec 21, 2023	SELL	$33.79 - $39.39 $946 - $1,102	-28 Reduced 53.85%	24 $2.71 Million
Q3 2017 Dec 21, 2023	SELL	$36.29 - $38.83 $834 - $893	-23 Reduced 30.67%	52 $5.68 Million
Q1 2017 Dec 21, 2023	SELL	N/A	-9 Reduced 10.71%	75 $7.06 Million
Q4 2016 Dec 21, 2023	BUY	N/A	84	84 $7.87 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on West Paces Advisors Inc. with notifications on news.